AzTrials
AzTrials

Child Sexual AbuseREVEALNCT06495502

To Disclose a Child Sexual Abuse Within Child & Adolescent Psychiatry Services

An observational study of Child Sexual Abuse, run by Anne Revah-Levy at 5 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Mental health professionals investigating child sexual abuse (CSA) among children and adolescents is a major public health challenge. Many studies have shown the obstacles to disclose, with professionals having difficulties to address this issue and survivors having difficulties to disclose. Read more about this study

Who is it for?
Ages 12 to 25 years
Conditions the study is for
Child Sexual Abuse
What is being tested?
semi-structured interview
Type of treatment
Injection or infusion
How many people
90 participants
Where
5 sitesFrance
Study dates
1 Jan 2024to 30 Jun 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 25 years
  • All sexes
  • Child, Adult

Study population: The population under study is divided into three sub-groups * (1) adolescents and young adults aged between 12 and 25, CSA victims, who have been receiving child \& adolescent psychiatry treatment. * (2) victim parents with an history of disclosure within the child \& adolescent psychiatry treatment. * (3) Child \& adolescent mental health professionals who have experienced, directly or indirectly, at least one situation of CSA disclosure by a minor patient.

Who may be able to join

  • Adolescents and young adults from four child \& adolescent psychiatric services in Argenteuil (SUPADO), Rouen, Lyon, Colombes and Rennes. T
  • in a well-identified care path
  • Age: 12-25 years old
  • have experienced Child Sexual Abuse (CSA)
  • Child \& adolescent psychiatry treatment prior to majority and after CSA, regardless the reason for this treatment
  • Parents with a Son/daughter on a well-identified care path, victim of CSA, with a disclosure during child \& adolescent psychiatry treatment
  • Child \& adolescent mental health professionals

Who cannot join

  • for adolescents, acute symptoms
  • for parents, in the situation of intrafamily CSA perpetrated by a parent, this parent will be excluded

Trial locations and contacts

5 sites in 1 country.

Jordan Sibeoni, MD PhD contact

0033134232598

jordan.sibeoni@ch-argenteuil.fr

Anne Revah-Levy, MD PhD contact

0033134232598

anne.revah-levy@ch-argenteuil.fr

5 sites in 1 country

France5 sites, 5 recruiting
  • CHVictorDupouy

    Argenteuil, Île-de-France Region, 95100

    Jordan Sibeoni, MD PhD, 0033134232598, jordan.sibeoni@ch-argenteuil.fr

    Recruiting
  • Hopital Femme Mère Enfant, Hospices Civils de Lyon

    Bron, Rhone, 69500

    Pierre Fourneret, MD PhD, 0 825 08 25 69, pierre.fourneret@chu-lyon.fr

    Recruiting
  • Hôpital Louis Mourier

    Colombes, Hauts De Seine, 92700

    Caroline Dubertret, MD PhD, 01 47 60 61 62, caroline.dubertret@aphp.fr

    Recruiting
  • Pôle Hospitalo-Universitaire de Psychiatrie de l'enfant et l'adolescent de Rennes

    Rennes, Ille-et-Vilaine, 35703

    Solenne Kermarrec, MD PhD, 02 99 28 43 21, solennkermarrec@yahoo.fr

    Recruiting
  • CHU Rouen/CH Rouvray

    Rouen, Seine Maritime, 7600

    Malaika Lasfar, MD, 02 32 88 89 90, malaika.lasfar@chu-rouen.fr

    Recruiting

Other trials in France

About this study

Official title: REVEAL To Disclose a Child Sexual Abuse Within Child & Adolescent Psychiatry Services: a Qualitative Study

Mental health professionals investigating child sexual abuse (CSA) among children and adolescents is a major public health challenge. Many studies have shown the obstacles to disclose, with professionals having difficulties to address this issue and survivors having difficulties to disclose. Many children, old enough to tell what happened to them, would disclose this traumatic event only many years after, but they suffer from psychiatric and/or somatic disorders meanwhile. CSA survivors presenting psychiatric symptoms very often receive a psychiatric treatment within child \& adolescent psychiatric (CAP) departments.

The investigators aim to better understand what is at stakes around the issue of disclosure of CSA by teenagers within CAP services, so to draw concrete implications to improve investigation efficacy and disclosure support by mental health professionals. To date, no study has ever explored these issues of investigating and disclosing CSA in CAP services. Qualitative methods are quite relevant here, aiming as they do, to in-depth explore complex issues, through the lived experience of the stakeholders.

Read more

The main objective of this study is to explore the lived experience of disclosing CSA among (i) adolescents and young adults followed in a CAP service, (ii) parents, and (iii) child \& adolescent mental health professionals working in CAP services who have experienced a CSA disclosure. Crossing perspectives will bring answers to the complex question: "how to disclose a CSA within a CAP service?" and will lead to concrete implications to improve treatment of children and adolescents with an history of CSA.

It is an exploratory qualitative multi-center design following the IPSE approach - Inductive Process to analyze the structure of lived experience-.

Read the detailed description

Mental health professionals investigating child sexual abuse (CSA) among children and adolescent is a major public health challenge. Many studies have shown the obstacles to disclose, with professionals having difficulties to address this issue and survivors having difficulties to disclose. Many children, old enough to tell what happened to them, would disclose this traumatic event only many years after, but they suffer from psychiatric and/or somatic disorders meanwhile. CSA survivors presenting psychiatric symptoms very often receive a psychiatric treatment within child \& adolescent psychiatric (CAP) departments. This follow-up is to be considered as an opportunity for them to disclose. Yet, according to the current literature, 20% of women and 39% of men would not disclose the CSA. Among children and adolescents, disclosure rate is estimated between 16 and 25%. Reducing disclosure delay and improving the quality of mental health professionals support around the issue of disclosure and its outcomes (individual, family, forensic), could improve survivors prognostic.

The investigators aim to better understand what is at stakes around the issue of disclosure of CSA by teenagers within CAP services, so to draw concrete implications to improve investigation efficacy and disclosure support by mental health professionals. To date, no study ever explored these issues of investigating and disclosing CSA in CAP services. Qualitative methods are quite relevant here, aiming as they do, to in-depth explore complex issues, through the lived experience of the stakeholders.

The main objective of this study is to explore the lived experience of disclosing CSA among (i) adolescents and young adults followed in a CAP service, (ii) parents, and (iii) child \& adolescent mental health professionals working in CAP services who have experienced a CSA disclosure. Crossing perspectives will bring answers to the complex question: "how to disclose a CSA within a CAP service?" and will lead to concrete implications to improve treatment of children and adolescents with an history of CSA.

It is an exploratory qualitative multi-center design following the IPSE approach - Inductive Process to analyze the structure of lived experience-. IPSE is a five-steps process: 1) set up a research group, 2) ensure the originality of the research, 3) organize recruitment and sampling intended to optimize exemplarity, 4) collect data that enable entry into the subjects 'experience, and 5) analyze the data. This final stage is composed of one individual descriptive phase, followed by two group phases: i) define the structure of the lived experience, and ii) translate the findings into concrete proposals that make a difference in care.

1 - Patients : i. be in a well-identified care path ii. Age: 12-25 years old iii. have experienced CSA iv. Child \& adolescent psychiatry treatment prior to majority and after CSA, regardless the reason for this treatment v. No acute symptoms 2. Parents i. child on a well-identified care path ii. child victim of CSA iii. Child disclosure during child \& adolescent psychiatry treatment iv. not being the perpetrator in case of intrafamilial CSA perpetrated by the mother or the father (the other parent could be included).

  1. Child \& adolescent mental health professionals i. have experienced, directly or indirectly, at least one situation of CSA disclosure by a minor patient.

This is a qualitative study, the number of participants required cannot be known beforehand, as it will be determined by the data saturation, based on the principle of theoretical sufficiency.

However, our experience in qualitative research allows us to propose a minimum of 30 participants per subgroup, for a total of 90 participants. This sample size will provide better visibility of our work and will ensure theoretical sufficiency.

Recruitment by local coordinators/co-investigators Data collection will be taken place within the five French departments.

The multicentric aspect is only to facilitate recruitment and to ensure data saturation but, in a qualitative study, it does not impact the quality and originality of the findings Intentional and non-probabilistic sampling strategy known as "Purposive Sampling" in maximum variation, that is to select exemplary/archetypal situations reflecting a variety of experiences, in order to obtain rich and diverse narratives, according to the principle of maximum variation. This is the technique of choice for sampling in qualitative research.

Data will be collected through semi-structured interviews by qualitative health researchers

All participants will be fully informed - orally and in writing- about the research and will express their non-opposition to participate in such research.

Non-opposition of the participants collected by the researcher and confirmed on the information and non-opposition form signed before any data collection and interview.

Being tested
semi-structured interview
Keywords
qualitative research, disclosure, child & adolescent psychiatry

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • semi-structured interviewOther

    Semi-structured interviews by qualitative health researchers

Study groups in NCT06495502
Study groupRoleWhat they receive
patientsi. be in a well-identified care path ii. Age: 12-25 years old iii. have experienced CSA iv. Child \& adolescent psychiatry treatment prior to majority and after CSA, regardless the reason for this treatment v. No acute symptoms
Receives: Other: semi-structured interview
Parentsi. child on a well-identified care path ii. child victim of CSA iii. Child disclosure during child \& adolescent psychiatry treatment iv. not being the perpetrator in case of intrafamilial CSA perpetrated by the mother or the father (the other parent could be included).
Receives: Other: semi-structured interview
child & adolescent mental health professionalsi. have experienced, directly or indirectly, at least one situation of CSA disclosure by a minor patient.
Receives: Other: semi-structured interview

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Lived experience of disclosure of child sexual abuse

    Participant-reported experiences in child sexual abuse disclosure as assessed using the Inductive Process to analyze the Structure of lived Experience (IPSE)

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2024
  2. Study start1 Jan 2024
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion30 Jun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Retrospective
Enrolment
90 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06495502
Sponsor's protocol ID
CHVictorDupouy
Acronym
REVEAL
Status last verified
Jul 2024
First submitted
27 Jun 2024
Last updated
10 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: anonymized data

Questions about this trial

What is this clinical trial studying?

An observational study of Child Sexual Abuse, run by Anne Revah-Levy at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jordan Sibeoni, MD PhD (0033134232598, jordan.sibeoni@ch-argenteuil.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Lived experience of disclosure of child sexual abuse (time frame: 2 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in